The present disclosure generally relates to monoblock orthopedic implants having bone-contacting surfaces adapted to allow for and promote bone ingrowth. More particularly, the present disclosure relates to monoblock implants made substantially of a ceramic material and including one or more bone-contacting surfaces that have been modified to allow for bone ingrowth. The present disclosure also relates to methods for making such implants.
Orthopedic implants are commonly used to replace some or all of a patient's joint such as a hip, knee, shoulder or elbow where deterioration of or damage to the joint has occurred due to aging, illness, injury or trauma. Orthopedic implants are commonly made of metal, ceramic, polymeric materials, or some combination thereof. For example, orthopedic implants commonly include a metal or ceramic portion that articulates against a polymeric bearing surface, or a metal surface that articulates against a facing metal or ceramic surface. In a hip replacement, the orthopedic hip implant will typically include a femoral component having a metallic or ceramic head that articulates against a polymeric (or metal or ceramic) surface of an acetabular cup. The polymeric bearing surface of the acetabular cup is typically contained within a metal or metal-containing shell which has been treated, formed, or otherwise adapted to allow for and promote bone ingrowth. The metal or metal-containing shell may incorporate, at its outer or bone contacting surface, porous titanium, tantalum, or a tantalum foam, such as Trabecular Metal™, a material used in orthopedic implants made by Zimmer, Inc., of Warsaw, Ind., and discussed in greater detail below.
In general, implants are classified as either modular or monoblock (i.e., single piece). Modular orthopedic implants are those where the implant is composed of two or more assembled parts connected by a locking mechanism and allowing for some of the constituent parts to be replaceable. For example, in a modular acetabular cup, the polymeric portion (that includes the bearing surface) is attached by mechanical means to the inside of a metal shell. With this arrangement, surgeons can replace a defective polymeric insert with another polymeric, ceramic or metal insert without disrupting the fixation of the shell to the bone. In contrast, monoblock implants are considered “single-piece” implants where the constituent components are integral and not interchangeable.
With respect to the interaction between articulating surfaces, a common concern is the generation of debris resulting from the relative motion of such surfaces. For example, motion between a metal component and a polymeric material, or the motion between facing metal surfaces may result in the release of polymeric or metallic debris into the surrounding environment. Such debris can interfere with the proper function of the orthopedic implant as well as cause an undesirable autoimmune response in the patient. For these reasons, research and development of low friction orthopedic implants that minimize the generation of debris is ongoing.
In addition to minimizing the friction between articulating surfaces and thereby limiting the production of debris, secure affixation of the implant within the bone is an extremely important aspect of joint replacement. Long-term stabilization of the implant is often achieved by incorporation or integration of the implant into the surrounding natural bone of the patient. Over time, bone from the surrounding tissue will grow into and around the implant and secure the implant to the bone tissue. This phenomenon is often referred to as osseointegration. To promote osseointegration, orthopedic implants are commonly provided with a bone-contacting surface that allows and promotes bone ingrowth. For example, many implants are provided with a porous bone-contacting surface which allows bone tissue to extend and grow into the pores of such surface. Examples of such implants are those that include a porous metal surface, such as titanium or tantalum, and implants including the previously mentioned Trabecular Metal™.
As noted above, in addition to the metal and polymeric materials used in many of the currently available implants, other materials such as ceramics have likewise been used in orthopedic implants, particularly modular implants. Ceramic materials and implants including ceramic articulating surfaces are believed to reduce the amount of debris generated by the motion of the articulating surfaces. One example of a ceramic implant is disclosed in U.S. Pat. No. 7,695,521, the contents of which are incorporated herein by reference. Another example of a ceramic-based implant is disclosed in WO 2009/103775 A2, the contents of which are also incorporated herein by reference. Ceramic materials for use with orthopedic implants and/or dental implants are described in U.S. Pat. No. 6,534,197, the contents of which are likewise incorporated herein by reference. While the use of ceramic materials in a modular implant, where the ceramic portion that includes the bearing surface is mechanically attached to a component that includes metal is known, monoblock implants (wherein the ceramic component is bonded to or otherwise attached without mechanical locking mechanisms) with an integral bone in-growth surface have been more difficult to achieve.
Accordingly, it would be desirable to provide a ceramic monoblock implant wherein the bone-contacting surface allows for a reliable and secure affixation through osseointegration with natural bone.
In one aspect, the present disclosure is directed to a monoblock orthopedic implant, including a ceramic substrate having an inner bearing surface and a treated outer surface. The monoblock implant includes a metallic scaffold adapted for osseointegration that is bonded to the treated outer surface of the substrate.
In another aspect, the present disclosure is directed to a method of making a monoblock implant having a ceramic bearing surface or a ceramic articulating surface and a treated outer surface adapted for osseointegration of the implant with natural bone. The method includes providing a ceramic substrate and treating the substrate to provide an oxygen rich surface. A least one layer of metal is then deposited onto the oxygen rich surface so as to provide a modified outer surface. In a further step, an osseointegrative scaffold is then bonded to the modified surface of the ceramic monoblock implant.
The present disclosure generally relates to monoblock orthopedic implants that include articulating or bearing surfaces made of non-polymeric, non-metallic materials such as low friction ceramic materials. Monoblock orthopedic implants of the type disclosed herein also include an integral bone-contacting surface that allows for bone ingrowth, i.e., osseointegration.
In one embodiment, the implant includes at least an articulating or bearing surface made of a non-metallic, non-polymeric material such as ceramic. Indeed, in an exemplary embodiment, implants of the type disclosed herein are made substantially of ceramic. In accordance with the present disclosure, although the monoblock implant is made substantially of ceramic, the portion of the implant that interfaces and is attached to the bone, i.e., the bone-contacting surface is modified to provide a surface that allows for and promotes bone ingrowth.
As noted above, implants of the present disclosure are monoblock implants in that they are comprised of two or more different portions or constituent parts bonded together to provide an integral implant. As such, substantially ceramic monoblock implants are distinguished from modular implants that include ceramic components in that the components are not separable and do not utilize locking mechanisms (as is common in modular implants) to attach or assemble together the separable components of the implant. Thus, monoblock implants of the present disclosure avoid some of the potential drawbacks associated with modular implants such as reliability of the locking mechanisms and the possible introduction of unwanted debris which may contribute to implant failure and autoimmune responses in the patient.
In accordance with the present invention, the inner bearing surface may be made of a low-friction, non-metallic, non-polymeric material. Preferably, the articulating surface is made of a ceramic material that is suitable for use in biomedical applications. More typically, the implant comprises a ceramic substrate made substantially or even entirely of the low friction, non-metallic, non-polymeric material, such as ceramic with a selected surface of the ceramic substrate modified to provide the bone-contacting layer as described in detail below.
The ceramic material selected is preferably suitable and approved for human use, i.e., biocompatible. Preferably, the ceramic material is likewise corrosion resistant, substantially wear resistant, and has a low coefficient of friction. The ceramic material should also have good mechanical strength. Examples of suitable ceramic materials include, but are not limited to, aluminum oxide, zirconium oxide, silicon nitride, zirconia-toughened alumina (ZTA) and alumina-toughened zirconia (ATZ).
The implant includes an outer surface that has been adapted to allow for and promote osseointegration of the implant with the natural bone of the patient. The outer surface preferably includes a porous metallic material selected to allow for and promote bone growth. Suitable materials include certain metallic materials based on, for example, titanium and tantalum. Certain metals or metal-containing materials are sufficiently porous or can be deposited in a way that creates a porous surface that allows for bone ingrowth. In a preferred embodiment, the metallic materials that can be used to provide the osseointegrative surface of the implant include metallic foams, such as titanium foam, tantalum foam, or stainless steel foam.
One example of suitable metallic foam is Trabecular Metal™. Trabecular Metal™ is a material used in orthopedic implants made by Zimmer, Inc., of Warsaw, Ind., and is described in, for example, U.S. Pat. No. 5,282,861, which is incorporated herein by reference. Trabecular Metal™ approximates the physical and mechanical properties of natural bone. It is highly porous and conducive to bone growth. Trabecular Metal™ has good corrosion resistance and is, of course, biocompatible. Trabecular Metal™ is formed by coating the surface of a pre-formed carbon foam with tantalum metal by, for example, chemical vapor deposition (CVD).
The present disclosure is directed to a method of making a monoblock implant having a ceramic bearing surface or a ceramic articulating surface and a treated outer surface adapted for osseointegration of the implant with natural bone. In the method, a ceramic substrate is provided. The ceramic substrate may be pre-formed in the shape of the desired orthopedic implant. The substrate or pre-form may be made substantially of a ceramic material, such as aluminum oxide, zirconium oxide, or silicon nitride.
The bone interfacing surface of the ceramic pre-form is preferably activated to provide a surface for bonding materials adapted for osseointegration, as well as for intermediate coatings, layers and depositions that allow for integral attachment of the bone ingrowth promoting material to the ceramic substrate. For example the outer surface may be activated or otherwise treated to provide an oxygen rich surface. Inasmuch as ceramic by itself does not provide the desired osseointegrative and attachment properties, treating or activating the ceramic outer surface to provide an oxygen-rich surface allows for subsequent bonding of the osseointegrative materials described below.
The oxygen rich surface may be provided in several different ways. For example, an oxygen rich outer surface may be provided by subjecting the ceramic surface to oxygen plasma etching or multiple energy oxygen ion implantation. Ion beam implantation is a process that changes the physical and electronic properties of a material by forcibly embedding different types of ions onto the material. In general, the ion implanter includes an ionization chamber where ions are created and an accelerator where they are boosted up to speeds high enough to penetrate the target material to the desired depth for example with an applying energy of approximately 200-800 KeV.
Once the ceramic surface has been treated to provide an oxygen rich activated surface, such activated surface may be further treated by depositing one or more metallic materials onto the surface. The deposited metallic materials (which can be provided as a paint, coating or sheet metal) are selected such that the metal firmly bonds to the activated oxygen rich surface of the ceramic pre-form and likewise bonds to a final osseointegrative, i.e., bone-contacting surface of the implant. For example, where the osseointegrative bone-contacting surface includes the previously described metallic foams, materials that may bond to such foams and the ceramic substrate include titanium, titanium-aluminum-vanadium or zirconium, and/or alloys of one or more of the above.
The activated ceramic surface is preferably treated with multiple layers or depositions of a metal or metallic-based material. The multiple materials may include three deposited layers or coatings of selected metallic materials. The layers or coatings may be titanium layers, while an intermediate layer may be any material that can serve as a thermal expansion compensator, which is described in greater detail below. Typically, the layers are applied sequentially and the combined multi-layered construct may have a thickness of typically between 3-5 μm and up to about 1 mm. Of course, the thickness of the multi-layered construct will depend, in part, on the type and size of implant. The layers may be applied by a variety of techniques including, but not limited to, electron beam evaporation, sputter deposition, plasma spray, spray painting of dispersed powder suspensions, and other comparable processes that will be known to those of skill in the art.
The ceramic substrate may be further modified to include an outer bone-contacting, osseointegrative surface. The outer bone-contacting surface may be provided as a pre-formed scaffold that is attached to the modified surface. The scaffold may be provided in any shape that conforms to the desired surface of the selected implant component. The scaffold may be made by casting. Alternatively, scaffold may be made by providing a carbon foam in a predetermined shape and depositing the desired (metal) material onto the foam. In yet another alternative, the scaffold may be made by bubbling gas into a molten metal.
In any event, the scaffold is preferably bonded to the implant substrate by, for example, diffusion bonding.
After diffusion bonding, the finished implant may undergo further finishing and shaping, followed by sterilization and packaging.
a is an enlarged perspective view of the humeral head component of the implant system of
a is an enlarged perspective view of the ankle implant system of
a is a cross-sectional view of a pre-formed ceramic substrate for use in the method of making a monoblock implant in accordance with the present disclosure;
b is a cross-sectional view of the pre-formed substrate of
a is an enlarged cross-sectional view of the deposited multi-layer of metal of
Shown in
Turning more particularly to
Acetabular cup 20, shown in
In accordance with the present disclosure, at least articulating surface 22 of cup 20 is made of a low-friction, non-metallic, non-polymeric material. Preferably, articulating surface 22 is made of a ceramic material that is suitable for use in biomedical applications. More typically, entire cup 20 is made substantially or even entirely of the low friction, non-metallic, non-polymeric material, such as ceramic with a selected surface (e.g., surface 24) of the ceramic cup modified to provide the bone-contacting layer as described in detail below.
The ceramic material selected must be suitable and approved for human use, i.e., biocompatible. Preferably, the ceramic material is likewise corrosion resistant, substantially wear resistant, and has a low coefficient of friction. The ceramic material should also have good mechanical strength. Examples of suitable ceramic materials include, but are not limited to, aluminum oxide, zirconium oxide, silicon nitride, zirconia-toughened alumina (ZTA) and alumina-toughened zirconia (ATZ).
As further shown in
One example of suitable metallic foam is Trabecular Metal™. Trabecular Metal™ is a material used in orthopedic implants made by Zimmer, Inc., of Warsaw, Ind., and is described in, for example, U.S. Pat. No. 5,282,861, which is incorporated herein by reference. Trabecular Metal™ approximates the physical and mechanical properties of natural bone. It is highly porous and conducive to bone growth. Trabecular Metal™ has good corrosion resistance and is, of course, biocompatible. Trabecular Metal™ is formed by coating the surface of a pre-formed carbon foam with tantalum metal by, for example, chemical vapor deposition (CVD).
As previously noted, the methods and systems described above are not limited to a acetabular cups for hip implant systems. Other implant components and other implant systems may also utilize the methods and systems described herein.
For example, as shown in
In yet another example of providing a monoblock implant made substantially of ceramic and including an osseointegrative surface,
Referring to
Thus, in its most general form, a monoblock ceramic-based implant of the present disclosure includes a ceramic articulating surface and an integrally bonded bone-contacting surface that allows for and promotes bone-in growth bonded thereto. However, as will become apparent from the following discussion of the method of making such implants, the monoblock implant and the starting pre-form is preferably subjected to one or more treatments and/or depositions of other materials that allow for effective attachment of the bone-contacting material to the pre-form(ed) substrate. Such treatments and/or depositions may or may not be clearly visible to the naked eye upon inspection of a finished implant. However, for purposes of clarity and understanding, they are shown in the
Turning now to the method of making monoblock implants of the present disclosure, such orthopedic implants can be made in several different ways.
As shown in
Bone interfacing surface 42 of ceramic pre-form 40 is preferably activated to provide a surface for bonding materials adapted for osseointegration, as well as for intermediate coatings, layers and depositions that allow for integral attachment of the bone ingrowth promoting material to the ceramic substrate. For example, as shown in
An oxygen rich surface 42 may be provided in several different ways. For example, an oxygen rich outer surface 42 may be provided by subjecting the ceramic surface to oxygen plasma etching.
Another method for imparting the oxygen rich properties to the ceramic outer surface 42 is by multiple energy oxygen ion implantation. Ion beam implantation is a process that changes the physical and electronic properties of a material by forcibly embedding different types of ions onto the material. In general, the ion implanter includes an ionization chamber where ions are created and an accelerator where they are boosted up to speeds high enough to penetrate the target material to the desired depth. In accordance with the present method, the ions are oxygen ions that are embedded onto the ceramic outer surface 42. The oxygen ion implantation method described herein includes applying energy of approximately 200-800 KeV.
Once the ceramic surface has been treated to provide an oxygen rich activated surface, such activated surface 42 may be further treated by depositing one or more metallic materials onto the surface. The deposited metallic materials (which can be provided as a paint, coating or sheet metal) are selected such that the metal firmly bonds to the activated oxygen rich surface of the ceramic pre-form 40 and likewise bonds to a final osseointegrative, i.e., bone-contacting surface of the implant. For example, where the osseointegrative bone-contacting surface includes the previously described metallic foams, materials that may bond to such foams and the ceramic substrate include titanium, titanium-aluminum-vanadium or zirconium, and/or alloys of one or more of the above.
In one embodiment, the activated ceramic surface is preferably treated with multiple layers or depositions of a metal or metallic-based material as generally depicted in
In one embodiment, layers or coatings 50 and 52 may be titanium layers, while intermediate layer 54 may be any material that can serve as a thermal expansion compensator which is described in greater detail below. Typically, each of the layers 50, 52 and 54 will be applied sequentially and the combined multi-layered construct 49 (
As shown in
As shown in
In any event, scaffold 56 is preferably bonded to implant substrate 40 by, for example, diffusion bonding. Diffusion bonding of scaffold 56 to multi-layer 49 may be carried out at temperatures higher than about 800° C. and under torques of at least 10 Nm. As discussed above in connection with
The finished implant 58 (
After diffusion bonding, the finished implant 58 may undergo further finishing and shaping, followed by sterilization and packaging.
In a further aspect, the methods or devices described herein may find application to or be embodied in dental implants, such as dental crowns. Shown in
In one embodiment, cap 82 may include a central aperture (not shown) through which a driver may be introduced to screw or otherwise attach screw or other member to the bone. Once dental crown 80 has been secured, the aperture is preferably filled with a composite material. Alternatively, as shown in
It will be understood that the embodiments above are illustrative of some of the applications of the principles of the present subject matter. Numerous modifications may be made by those skilled in the art without the departing from the spirit and scope of the claimed subject matter, including those combinations of features that are individually disclosed or claimed herein. For these reasons, the scope hereof is not limited to the above description.
This application is a U.S. National Stage Filing under 35 U.S.C. 371 of International Patent Application Serial No. PCT/US2011/060973, filed on Nov. 16, 2011, published on May 24, 2012 as WO 2012/068239 A1, which claims the benefit of priority under 35 U.S.C. 119(e) of U.S. Provisional Patent Application Ser. No. 61/414,729 filed on Nov. 17, 2010, the benefit of priority of each of which is claimed hereby and the entire contents of each of which are incorporated herein by reference in its entirety.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2011/060973 | 11/16/2011 | WO | 00 | 9/20/2013 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2012/068239 | 5/24/2012 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
5030396 | Saita et al. | Jul 1991 | A |
5702474 | McCandliss | Dec 1997 | A |
6139585 | Li | Oct 2000 | A |
6171310 | Giordano | Jan 2001 | B1 |
6447550 | Hunter | Sep 2002 | B1 |
6626950 | Brown | Sep 2003 | B2 |
6719987 | Burrell et al. | Apr 2004 | B2 |
6833197 | Dong | Dec 2004 | B1 |
6858042 | Nadler | Feb 2005 | B2 |
6869701 | Aita | Mar 2005 | B1 |
7473278 | Hunter | Jan 2009 | B2 |
7578851 | Dong | Aug 2009 | B2 |
7771483 | Justin | Aug 2010 | B2 |
7867280 | Goble | Jan 2011 | B2 |
7896926 | Hunter | Mar 2011 | B2 |
8012205 | Plouhar et al. | Sep 2011 | B2 |
8399008 | Webster et al. | Mar 2013 | B2 |
8415019 | Pawar | Apr 2013 | B2 |
8556972 | Gordon | Oct 2013 | B2 |
8556981 | Jones | Oct 2013 | B2 |
8556987 | Hunter | Oct 2013 | B2 |
8862258 | Nimal | Oct 2014 | B2 |
9011965 | Gan | Apr 2015 | B2 |
20010039455 | Simon | Nov 2001 | A1 |
20020018798 | Sewing et al. | Feb 2002 | A1 |
20020107520 | Hoffman | Aug 2002 | A1 |
20030099762 | Zhang | May 2003 | A1 |
20030114936 | Sherwood | Jun 2003 | A1 |
20030153981 | Wang | Aug 2003 | A1 |
20040122524 | Hunter | Jun 2004 | A1 |
20040153165 | Li et al. | Aug 2004 | A1 |
20060210494 | Rabiei | Sep 2006 | A1 |
20070113951 | Huang | May 2007 | A1 |
20070118243 | Schroeder et al. | May 2007 | A1 |
20070150068 | Dong et al. | Jun 2007 | A1 |
20070181239 | Yamazawa et al. | Aug 2007 | A1 |
20070184299 | Wei | Aug 2007 | A1 |
20070287027 | Justin et al. | Dec 2007 | A1 |
20090192610 | Case et al. | Jul 2009 | A1 |
20090226668 | Simon | Sep 2009 | A1 |
20100137990 | Apatsidis et al. | Jun 2010 | A1 |
20100174377 | Heuer | Jul 2010 | A1 |
20100174383 | Pawar | Jul 2010 | A1 |
20100178312 | Webster et al. | Jul 2010 | A1 |
20100268337 | Gordon | Oct 2010 | A1 |
20100310623 | Laurencin et al. | Dec 2010 | A1 |
20100318108 | Datta et al. | Dec 2010 | A1 |
20100331979 | McDade et al. | Dec 2010 | A1 |
20100331998 | Ringeisen | Dec 2010 | A1 |
20110003083 | Yang | Jan 2011 | A1 |
20110014258 | Gan | Jan 2011 | A1 |
20110143127 | Gupta | Jun 2011 | A1 |
20110251698 | Gupta | Oct 2011 | A1 |
20120253474 | Klein et al. | Oct 2012 | A1 |
20130001090 | Rubinson et al. | Jan 2013 | A1 |
20130053938 | Miller et al. | Feb 2013 | A1 |
20130189606 | Ruettinger | Jul 2013 | A1 |
20130190888 | Novak Krmpotic et al. | Jul 2013 | A1 |
20130190889 | Li | Jul 2013 | A1 |
20130310948 | Luscher | Nov 2013 | A1 |
20140005796 | Popoola | Jan 2014 | A1 |
20140018931 | Gillard et al. | Jan 2014 | A1 |
20140277530 | Stalcup | Sep 2014 | A1 |
20140308628 | Carrad | Oct 2014 | A1 |
20150004042 | Nimal | Jan 2015 | A1 |
20150110846 | Yu et al. | Apr 2015 | A1 |
Number | Date | Country |
---|---|---|
WO-2009103775 | Aug 2009 | WO |
WO-2012068239 | May 2012 | WO |
Entry |
---|
“European Application Serial No. 09774115.1, Communication pursuant to Rules 161 (1) and 162 EPC mailed Jul. 26, 2013”, 2 pgs. |
“International Application Serial No. PCT/US2011/060973, International Preliminary Report on Patentability mailed May 30, 2013”, 8 pgs. |
“International Application Serial No. PCT/US2011/060973, International Search Report mailed Feb. 16, 2012”, 4 pgs. |
“International Application Serial No. PCT/US2011/060973, Written Opinion mailed Feb. 16, 2012”, 8 pgs. |
Barth, E., et al., “Bioactive glass ceramic on titanium substrate: The effect of molybdenum as an intermediate bond coating”, Biomaterials, Elsevier Science Publishers BV vol. 7 No. 4, (Jul. 1, 1986), 273-276 pgs. |
Number | Date | Country | |
---|---|---|---|
20140005796 A1 | Jan 2014 | US |
Number | Date | Country | |
---|---|---|---|
61414729 | Nov 2010 | US |